Biomarin Pharmaceutical (BMRN) Revenue (2009 - 2026)
Biomarin Pharmaceutical (BMRN) revenue from Jun 30, 2009 to Mar 31, 2026. The TTM Biomarin Pharmaceutical (BMRN) revenue is $3.24B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Biomarin Pharmaceutical (BMRN) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +9.90% |
| 3 Years TTM | +14.27% |
| 5 Years TTM | +11.94% |
| 10 Years TTM | +13.38% |
| All Time TTM | +17.44% |
Annual Revenue change of Biomarin Pharmaceutical (BMRN)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $766M | -76.21% |
| 2025 | $3.22B | +12.87% |
| 2024 | $2.85B | +17.97% |
| 2023 | $2.42B | +15.42% |
| 2022 | $2.10B | +13.53% |
| 2021 | $1.85B | -0.76% |
| 2020 | $1.86B | +9.18% |
| 2019 | $1.70B | +14.27% |
| 2018 | $1.49B | +13.52% |
| 2017 | $1.31B | +17.62% |
| 2016 | $1.12B | +25.50% |
| 2015 | $890M | +18.77% |
| 2014 | $749M | +36.61% |
| 2013 | $548M | +9.54% |
| 2012 | $501M | +13.45% |
| 2011 | $441M | +17.30% |
| 2010 | $376M | +15.90% |
| 2009 | $325M | +9.50% |
| 2008 | $296M | N/A |
Comparison Biomarin Pharmaceutical (BMRN) five years revenue CAGR with competitors
Biomarin Pharmaceutical (BMRN) five years revenue CAGR is 11.94%.